Suppr
超能文献

The Path to Paxlovid.

作者信息

Halford Bethany

出版信息

ACS Cent Sci. 2022 Apr 27;8(4):405-407. doi: 10.1021/acscentsci.2c00369. Epub 2022 Apr 4.

DOI:10.1021/acscentsci.2c00369

PMID:35505871

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9052793/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f036/9052793/7d278ccdb7dd/oc2c00369_0003.jpg

相似文献

The Path to Paxlovid.

ACS Cent Sci. 2022 Apr 27;8(4):405-407. doi: 10.1021/acscentsci.2c00369. Epub 2022 Apr 4.

Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports.

BMJ. 2021 Nov 8;375:n2713. doi: 10.1136/bmj.n2713.

Covid-19: What is the evidence for the antiviral Paxlovid?

BMJ. 2022 Apr 27;377:o1037. doi: 10.1136/bmj.o1037.

Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection.

Am J Kidney Dis. 2022 Apr;79(4):480-482. doi: 10.1053/j.ajkd.2022.01.001. Epub 2022 Jan 12.

Table: Treatments considered for COVID-19.

Med Lett Drugs Ther. 2020 Apr 6;62(1595):e1-e280.

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

Antibiotics (Basel). 2022 Feb 9;11(2):220. doi: 10.3390/antibiotics11020220.

Using Parcels to Convert Path Analysis Models Into Latent Variable Models.

Multivariate Behav Res. 2005 Apr 1;40(2):235-59. doi: 10.1207/s15327906mbr4002_4.

Path-length distribution and path-length-resolved Doppler measurements of multiply scattered photons by use of low-coherence interferometry.

Opt Lett. 2001 Oct 1;26(19):1492-4. doi: 10.1364/ol.26.001492.

An investigation of the accuracy of standardized path coefficients.

J Gen Psychol. 2011 Jul-Sep;138(3):201-14. doi: 10.1080/00221309.2011.584584.

Modeling the spontaneous initiation of the polymerization of methyl methacrylate.

J Mol Model. 2008 Nov;14(11):1053-64. doi: 10.1007/s00894-008-0344-6. Epub 2008 Jul 22.

引用本文的文献

Design, Synthesis, and Biological Evaluation of Peptidomimetic Tetrahydropyrrole Spirodihydroindolones as SARS-CoV-2 3CL Protease Inhibitors.

ACS Med Chem Lett. 2025 Apr 14;16(5):790-796. doi: 10.1021/acsmedchemlett.4c00637. eCollection 2025 May 8.

Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational Simulations.

J Med Chem. 2025 Apr 24;68(8):8269-8294. doi: 10.1021/acs.jmedchem.4c02941. Epub 2025 Apr 5.

A coronavirus assembly inhibitor that targets the viral membrane protein.

Nature. 2025 Apr;640(8058):514-523. doi: 10.1038/s41586-025-08773-x. Epub 2025 Mar 26.

Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds.

J Enzyme Inhib Med Chem. 2025 Dec;40(1):2460045. doi: 10.1080/14756366.2025.2460045. Epub 2025 Feb 6.

An Investigation of Nirmatrelvir (Paxlovid) Resistance in SARS-CoV-2 M.

ACS Bio Med Chem Au. 2024 Oct 8;4(6):280-290. doi: 10.1021/acsbiomedchemau.4c00045. eCollection 2024 Dec 18.

Insights into SARS-CoV-2: Small-Molecule Hybrids for COVID-19 Treatment.

Molecules. 2024 Nov 15;29(22):5403. doi: 10.3390/molecules29225403.

Advances in the Search for SARS-CoV-2 M and PL Inhibitors.

Pathogens. 2024 Sep 24;13(10):825. doi: 10.3390/pathogens13100825.

Simultaneous reaction- and analytical model building using dynamic flow experiments to accelerate process development.

Chem Sci. 2024 Jul 1;15(31):12523-12533. doi: 10.1039/d4sc01703j. eCollection 2024 Aug 7.

Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.

Clin Pathol. 2024 Jul 26;17:2632010X241263054. doi: 10.1177/2632010X241263054. eCollection 2024 Jan-Dec.

Fixing the Achilles Heel of Pfizer's Paxlovid for COVID-19 Treatment.

J Med Chem. 2024 Jul 25;67(14):11656-11661. doi: 10.1021/acs.jmedchem.4c01342. Epub 2024 Jul 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

The Path to Paxlovid.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译